Tyler Adam, MD
Obstetrics & Gynecology · Hastings, NENPI 1598963027
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $3,850 of the $3,977 with a category attached, or 96.8%. Pfizer accounts for 93.0% of it on its own, with 4 other manufacturers making up the rest. 2024 is the largest year on record at $3,700, more than ten times the $150 reported in 2020.
Across 5 payments — averaging $795.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$4K
- Galderma Laboratories, L.p.$150
- Zimmer Biomet$59
- Paragon 28, Inc.$47
- Medtronic$20
Across 382 payments — averaging $7435.42 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$2.1M
- Modernatx, Inc.$598K
- Abbott$46K
- Genbiopro, Inc.$39K
- GSK$32K
- Ferring International Pharmascience Center US$21K
- plus $40K from 2 others
What the payments were for
- Speaking & faculty fees$3,85097%
- Food & beverage$1273%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 1 | $3,700 |
| Galderma Laboratories, L.p. | 1 | $150 |
| Zimmer Biomet | 1 | $59 |
| Paragon 28, Inc. | 1 | $47 |
| Medtronic | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ABRYSVO$3,700
How this compares
$3,977 in reported general payments places this provider in the 85th percentile of 242 obstetrics & gynecology providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 77 | $3,169 |
| Estradiol (Once Weekly)Estradiol | 22 | $1,271 |
| Clobetasol Propionate | 25 | $1,217 |
| Oxybutynin Chloride | 19 | $308 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 16 | $210 |
| Fluconazole | 14 | $158 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 19 | $154 |
| Medroxyprogesterone Acetate | 16 | $57 |
| Ibuprofen | 20 | $52 |
| Tramadol Hcl | 12 | $17 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Hastings
- John CoteOmaha$236K
- Gregory HeidrickLincoln$80K
- Robin ClemmerOmaha$19K
- Angela GroneBeatrice$17K
- Chandra LjunggrenLincoln$13K
- Emily NeriLincoln$13K
- Alicia MuhleisenLincoln$11K
- Michael BiancoNorth Platte$9K
- Deann PaulsonBeatrice$9K
- Todd MartinLincoln$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.